Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
or

Biomea Fusion Inc (BMEA)

Biomea Fusion Inc (BMEA)
1.81 x 1 2.01 x 3
Post-market by (Cboe BZX)
1.99 -0.14 (-6.57%) 04/01/25 [NASDAQ]
1.81 x 1 2.01 x 3
Post-market 2.06 +0.07 (+3.52%) 16:24 ET
Quote Overview for Tue, Apr 1st, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
1.94
Day High
2.29
Open 2.24
Previous Close 2.13 2.13
Volume 1,217,400 1,217,400
Avg Vol 697,705 697,705
Stochastic %K 3.69% 3.69%
Weighted Alpha -78.75 -78.75
5-Day Change -0.7000 (-26.02%) -0.7000 (-26.02%)
52-Week Range 1.9400 - 14.4300 1.9400 - 14.4300
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 72,116
  • Shares Outstanding, K 36,239
  • Annual Sales, $ 0 K
  • Annual Income, $ -117,260 K
  • EBIT $ -151 M
  • EBITDA $ -150 M
  • 60-Month Beta -0.07
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.10

Options Overview Details

View History
  • Implied Volatility 115.85% ( -17.16%)
  • Historical Volatility 82.54%
  • IV Percentile 47%
  • IV Rank 28.66%
  • IV High 290.82% on 12/09/24
  • IV Low 45.55% on 06/06/24
  • Put/Call Vol Ratio 1.28
  • Today's Volume 271
  • Volume Avg (30-Day) 304
  • Put/Call OI Ratio 0.33
  • Today's Open Interest 17,739
  • Open Int (30-Day) 16,185

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.90
  • Number of Estimates 3
  • High Estimate -0.78
  • Low Estimate -1.08
  • Prior Year -1.09
  • Growth Rate Est. (year over year) +17.43%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.9400 +2.58%
on 04/01/25
Period Open: 2.8900
3.0760 -35.31%
on 03/24/25
-0.9000 (-31.14%)
since 02/28/25
3-Month
1.9400 +2.58%
on 04/01/25
Period Open: 3.8800
4.5900 -56.64%
on 01/24/25
-1.8900 (-48.71%)
since 12/31/24
52-Week
1.9400 +2.58%
on 04/01/25
Period Open: 15.3000
14.4300 -86.21%
on 04/04/24
-13.3100 (-86.99%)
since 04/01/24

Most Recent Stories

More News
Biomea Fusion, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

BMEA : 1.9900 (-6.57%)
Biomea Fusion Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Highlights

BMEA : 1.9900 (-6.57%)
Biomea Fusion Announces Leadership Transition

BMEA : 1.9900 (-6.57%)
Icovamenib Treatment in Patients with Severe Insulin-Deficient Diabetes Led to a Significant Improvement in Pancreatic Beta-cell Function with a 53% Mean Increase in C-peptide Levels 3 Months After Last Dose

BMEA : 1.9900 (-6.57%)
Biomea Fusion, Inc. Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

BMEA : 1.9900 (-6.57%)
Biomea Fusion to Unveil New Icovamenib Data at the 18th International Conference on Advanced Technologies & Treatments for Diabetes

BMEA : 1.9900 (-6.57%)
Biomea Fusion to Become a Diabetes & Obesity Medicines Company

BMEA : 1.9900 (-6.57%)
Biomea Fusion Reports New Preclinical Data on Icovamenib-Semaglutide Combination Study

BMEA : 1.9900 (-6.57%)
Biomea Fusion to Present at the 43rd Annual J.P. Morgan Healthcare Conference

BMEA : 1.9900 (-6.57%)
Biomea Fusion Announces Positive Topline Results from Ongoing Phase II COVALENT-111 Study in Patients with Type 2 Diabetes

BMEA : 1.9900 (-6.57%)

Business Summary

Biomea Fusion Inc. is a preclinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of irreversible small molecules to treat patients with genetically defined cancers. Biomea Fusion Inc. is based in REDWOOD CITY, Calif.

See More

Key Turning Points

3rd Resistance Point 2.5567
2nd Resistance Point 2.4233
1st Resistance Point 2.2067
Last Price 1.9900
1st Support Level 1.8567
2nd Support Level 1.7233
3rd Support Level 1.5067

See More

52-Week High 14.4300
Fibonacci 61.8% 9.6588
Fibonacci 50% 8.1850
Fibonacci 38.2% 6.7112
Last Price 1.9900
52-Week Low 1.9400

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trading Volatility: How to Use IV Rank & Percentile for Smarter Options Strategies